José Antonio
Rodríguez García
Investigador Senior
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublications in collaboration with researchers from Hospital de Gran Canaria Dr. Negrin (9)
2019
-
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
BMC neurology, Vol. 19, Núm. 1, pp. 167
-
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
Journal of Critical Care, Vol. 51, pp. 117-121
2015
-
Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
Critical Care, Vol. 19, Núm. 1
-
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction
BMC Neurology, Vol. 15, Núm. 1
2014
2013
2011
-
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Critical Care, Vol. 15, Núm. 2